<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Mol Vis</journal-id>
      <journal-id journal-id-type="iso-abbrev">Mol. Vis</journal-id>
      <journal-id journal-id-type="publisher-id">MV</journal-id>
      <journal-title-group>
        <journal-title>Molecular Vision</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1090-0535</issn>
      <publisher>
        <publisher-name>Molecular Vision</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24265541</article-id>
      <article-id pub-id-type="pmc">3834600</article-id>
      <article-id pub-id-type="publisher-id">226</article-id>
      <article-id pub-id-type="publisher-manuscript">2013MOLVIS0227</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Clinical characteristics of early retinal disease due to <italic>CDHR1</italic> mutation</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Ba-Abbad</surname>
            <given-names>Rola</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
          <xref ref-type="aff" rid="aff4">
            <sup>4</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sergouniotis</surname>
            <given-names>Panagiotis I.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Plagnol</surname>
            <given-names>Vincent</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Robson</surname>
            <given-names>Anthony G.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Michaelides</surname>
            <given-names>Michel</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Holder</surname>
            <given-names>Graham E.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Webster</surname>
            <given-names>Andrew R.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <aff id="aff1"><label>1</label>UCL Institute of Ophthalmology, University College London, London, UK</aff>
        <aff id="aff2"><label>2</label>Moorfields Eye Hospital, London, UK</aff>
        <aff id="aff3"><label>3</label>Genetics Institute, University College London, London, UK</aff>
        <aff id="aff4"><label>4</label>Ophthalmology Department, King Abdulaziz University Hospital, Riyadh, Saudi Arabia</aff>
      </contrib-group>
      <author-notes>
        <fn>
          <p>The first two authors contributed equally to this work.</p>
        </fn>
        <corresp id="cor1">Correspondence to: Andrew R. Webster, Moorfields Eye Hospital, 162 City Road London EC1V 2PD UK Phone: + 44(0)2075662260; FAX: + 44(0)2076086830; email: <email xlink:href="andrew.webster@ucl.ac.uk">andrew.webster@ucl.ac.uk</email></corresp>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2013</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>16</day>
        <month>11</month>
        <year>2013</year>
      </pub-date>
      <volume>19</volume>
      <fpage>2250</fpage>
      <lpage>2259</lpage>
      <history>
        <date date-type="received">
          <day>15</day>
          <month>4</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>14</day>
          <month>11</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2013 Molecular Vision.</copyright-statement>
        <copyright-year>2013</copyright-year>
        <copyright-holder>Molecular Vision</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited, used for non-commercial purposes, and is not altered or transformed.</license-p>
        </license>
      </permissions>
      <abstract>
        <sec>
          <title>Purpose</title>
          <p>To describe the early clinical and electrophysiological features of cone-rod dystrophy due to a mutation of cadherin-related family member 1 (<italic>CDHR1</italic>).</p>
        </sec>
        <sec>
          <title>Methods</title>
          <p>Three affected siblings from a consanguineous family were ascertained. The clinical data included retinal examination, Goldmann visual fields, fundus autofluorescence imaging, optical coherence tomography (OCT), and pattern and full-field electroretinograms. Exome sequencing was performed in two siblings.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>The three siblings presented at age 24, 18, and 16 years, respectively. Their main symptoms were blurred central vision, dyschromatopsia, and photoaversion. All were myopic with best-corrected visual acuities of 20/60, 20/60, and 20/40, respectively. Fundoscopy revealed a range of macular appearances from mild retinal pigment epithelial changes to symmetric, subfoveal pigmented lesions. Fundus autofluorescence imaging and OCT revealed evidence of mild structural abnormalities in the two older siblings. Electroretinography findings in all three patients indicated severe generalized cone-rod dysfunction. Mutational screening in the three siblings showed them to be homozygous for a previously reported frame-shifting mutation in exon 13 of <italic>CDHR1</italic>, c.1463delG, p.G488fs.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>The initial clinical signs in this specific retinopathy may be relatively subtle despite a significant functional deficit, with unusual, bilateral, subfoveal pigmented lesions in one 16-year-old patient. Lack of CDHR1 in the human retina causes symptoms related to cone photoreceptor dysfunction in the first instance. A near-normal retinal structure, at least in the first two decades, suggests that <italic>CDHR1</italic>-related retinopathy may be a good candidate for gene replacement or other novel stabilizing treatments.</p>
        </sec>
      </abstract>
      <custom-meta-group>
        <custom-meta>
          <meta-name>GalleyStatus</meta-name>
          <meta-value>Export to XML</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Introduction</title>
      <p>Retinal dystrophies are a highly heterogeneous group of progressive retinal degenerations that eventually lead to significant visual loss. They can be broadly classified according to the relative severity of generalized rod or cone system dysfunction, and include cone dystrophies, cone-rod dystrophies, and rod-cone dystrophies (also known as retinitis pigmentosa) [<xref ref-type="bibr" rid="r1">1</xref>]. Symptoms associated with cone dysfunction include reduction of visual acuity, impaired color vision, and photophobia [<xref ref-type="bibr" rid="r2">2</xref>,<xref ref-type="bibr" rid="r3">3</xref>]. Conversely, patients with rod dysfunction complain of nyctalopia [<xref ref-type="bibr" rid="r4">4</xref>].</p>
      <p>Cone-rod dystrophies can be inherited as autosomal dominant, autosomal recessive, or X-linked recessive traits [<xref ref-type="bibr" rid="r3">3</xref>]. Mutations in <italic>ABCA4</italic>, <italic>ADAM9</italic>, <italic>CERKL</italic>, <italic>PROM1</italic>, and <italic>RPGRIP1</italic> are associated with autosomal recessive cone-rod dystrophy [<xref ref-type="bibr" rid="r5">5</xref>-<xref ref-type="bibr" rid="r8">8</xref>]. Recently, mutations in cadherin-related family member 1 (<italic>CDHR1</italic>), a gene localized at chromosome 10q23.1, have also been associated with autosomal recessive retinal dystrophy in families of Middle Eastern, Asian, and Faroese origin [<xref ref-type="bibr" rid="r9">9</xref>-<xref ref-type="bibr" rid="r12">12</xref>]. <italic>CDHR1</italic> encodes the photoreceptor cadherin, a structural, transmembrane protein localized to the base of the rod and cone outer segments (OSs) and appears to be involved in maintaining the OS structure [<xref ref-type="bibr" rid="r13">13</xref>]. Only a few families with <italic>CDHR1</italic>-related retinopathy have been reported so far. There are very limited data on younger patients with the disorder; such data are important for determining the cell type first affected and to aid the clinician in making a timely diagnosis in childhood. Retinal signs are not pathognomonic and included irregular macular pigmentation, bull&#x2019;s eye maculopathy, metallic sheen at the macula, bone spicule pigment migration in the anterior retina, dense pigmentation, and marked outer retinal atrophic changes [<xref ref-type="bibr" rid="r9">9</xref>,<xref ref-type="bibr" rid="r10">10</xref>,<xref ref-type="bibr" rid="r12">12</xref>]. A mouse knockout model exists with affected animals having short, disorganized, and misaligned photoreceptor OSs leading to apoptotic photoreceptor cell death [<xref ref-type="bibr" rid="r13">13</xref>].</p>
      <p>The present report describes the early phenotype in a family in which, from clinical examination and detailed investigations, the specific molecular diagnosis was not initially apparent. Subsequent exome sequencing determined a homozygous null mutation in <italic>CDHR1</italic>.</p>
    </sec>
    <sec sec-type="methods">
      <title>Methods</title>
      <sec>
        <title>Participants and clinical assessment</title>
        <p>Three affected siblings from a consanguineous family of Pakistani origin were ascertained, following presentation to the inherited retinal disorders service at Moorfields Eye Hospital (family GC18832). Clinical testing and blood samples for genetic testing were obtained after informed consent by the adult patients and from the legal guardians of the younger sister. The study was endorsed by the Local Research Ethics Committee and adhered to the tenets of the Declaration of Helsinki.</p>
        <p>Clinical assessment included Snellen visual acuity, color vision testing using Ishihara pseudo-isochromatic color plates (Kanehara Shuppan Co., Ltd., Tokyo, Japan), and slit-lamp examination after pupillary dilation. Clinical imaging included spectral-domain optical coherence tomography (SD-OCT) and fundus autofluorescence (FAF) performed on a Spectralis HRA+OCT (Heidelberg Engineering GmbH, Heidelberg, Germany), and color fundus photography on a Topcon TRC-50DX (Topcon Medical Systems, Inc., Oakland, NJ). In addition, Goldmann visual fields (Haag Streit, Bern, Switzerland) were assessed using targets that ranged from I4e to V4e. Full field electroretinograms (ERG), pattern electroretinograms (PERG) were recorded on a custom-built ERG system; multifocal electroretinograms (mfERG) were recorded on a Roland system (Roland Consult, Brandenburg, Germany) using techniques that incorporated the Standards of the International Society for Clinical Electrophysiology of Vision [<xref ref-type="bibr" rid="r14">14</xref>-<xref ref-type="bibr" rid="r16">16</xref>].</p>
      </sec>
      <sec>
        <title>Genetic studies</title>
        <p>Exome sequencing was performed in family members II:2 and II:3 (<xref ref-type="fig" rid="f1">Figure 1</xref>) using the solution-phase Agilent SureSelect 50 Mb exome capture (SureSelect Human All Exon Kit; Agilent, Wokingham, UK) and the Illumina HiSeq2000 sequencer (Illumina, San Diego, CA). Reads were aligned to the hg19 human reference sequence using Novoalign (Novocraft, Selangor, Malaysia) version 2.05. The ANNOVAR tool (OpenBioinformatics, Beverly, MA) was used to annotate single-nucleotide polymorphisms and small insertions/deletions. To detect the likely disease-causing variant, heuristic filtering methods were used as previously described [<xref ref-type="bibr" rid="r17">17</xref>]. Variants were prioritized by their presence in shared regions of homozygosity, assuming the inheritance of an identical chromosomal segment from a single founder from both related parents.</p>
        <fig id="f1" fig-type="figure" position="float">
          <label>Figure 1</label>
          <caption>
            <p>Identification of a CDHR1 mutation in individuals from a family with cone-rod dystrophy. <bold>A</bold>: An assembly of paired-end reads following Illumina HiSeq2000 sequencing and alignment with ANNOVAR 2.05, viewed using IGV2.3.0. Samples derived from patients II:2 and II:3 are shown in the top two lanes with three control samples from the same sequencing run, shown below. All 29 and 47 reads from II:2 and II:3, respectively, are consistent with deletion of a single G nucleotide in a run of 5 Gs from the wild-type sequence of exon 13 of cadherin-related family member 1 (CDHR1). <bold>B</bold>: Pedigree of family GC18832. The pedigree of the affected sibship. The family is an Asian, first-cousin consanguineous pedigree with three affected siblings. Open and closed symbols represent unaffected and affected individuals, respectively. <bold>C</bold>: Chromatograms of Sanger DNA sequencing surrounding the CDHR1 variant c.1463delG, p.G488fs are shown for patients II:2, II:3, and II:6, as well as an unrelated control sample.</p>
          </caption>
          <graphic xlink:href="mv-v19-2250-f1"/>
        </fig>
      </sec>
    </sec>
    <sec sec-type="results">
      <title>Results</title>
      <p>Clinical, imaging, visual field, and electrophysiological findings are summarized in <xref ref-type="table" rid="t1">Table 1</xref>, and are detailed below for family members II:2, II:3, and II:6 (<xref ref-type="fig" rid="f1">Figure 1</xref>). Parents and asymptomatic family members were not examined and parental DNA was unavailable for analysis. Exon capture and high-throughput sequencing of DNA from family members II:2 and II:3, in large shared chromosomal areas of contiguous homozygosity, revealed homozygosity for a previously reported frame-shifting mutation in exon 13, c.1463delG, p.G488fs [<xref ref-type="bibr" rid="r9">9</xref>] in both siblings. No other likely disease-causing mutations in genes previously associated with retinal disease were identified in either sample. Direct Sanger sequencing of the DNA from members II:2 and II:3 confirmed the mutation and showed the same homozygous mutation in II:6 (<xref ref-type="fig" rid="f1">Figure 1</xref>).</p>
      <table-wrap id="t1" position="float">
        <label>Table 1</label>
        <caption>
          <title>Summary of the clinical and electrophysiological data.</title>
        </caption>
        <table frame="hsides" rules="groups">
          <col width="80" span="1"/>
          <col width="96" span="1"/>
          <col width="117" span="1"/>
          <col width="57" span="1"/>
          <col width="171" span="1"/>
          <col width="130" span="1"/>
          <thead>
            <tr>
              <th valign="middle" align="center" scope="col" rowspan="1" colspan="1">Case/age&#x2028;(years)/gender</th>
              <th valign="middle" align="center" scope="col" rowspan="1" colspan="1">Presenting symptoms</th>
              <th valign="middle" align="center" scope="col" rowspan="1" colspan="1">BCVA/refractive error</th>
              <th valign="middle" align="center" scope="col" rowspan="1" colspan="1">Color vision</th>
              <th valign="middle" align="center" scope="col" rowspan="1" colspan="1">Fundoscopic features</th>
              <th valign="middle" align="center" scope="col" rowspan="1" colspan="1">ERG</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td valign="top" align="left" scope="row" rowspan="1" colspan="1">1/24/F<hr/></td>
              <td valign="top" align="left" rowspan="1" colspan="1">Progressive loss of central vision; photophobia<hr/></td>
              <td valign="top" align="left" rowspan="1" colspan="1">OU: 20/60;&#x2028;OD: -4.75/-1.25x30&#x2028;OS: -3.75/-1.00x160<hr/></td>
              <td valign="top" align="left" rowspan="1" colspan="1">OD:1/17&#x2028;OS: 2/17<hr/></td>
              <td valign="top" align="left" rowspan="1" colspan="1">RPE changes at the macula; normally appearing peripheral retina<hr/></td>
              <td valign="top" align="left" rowspan="1" colspan="1">Undetectable PERG;&#x2028;Scotopic bright flash ERG is markedly delayed and subnormal;&#x2028;Severely delayed and reduced cone responses.<hr/></td>
            </tr>
            <tr>
              <td valign="top" align="left" scope="row" rowspan="1" colspan="1">2/18/M<hr/></td>
              <td valign="top" align="left" rowspan="1" colspan="1">Reduced visual acuity, color blindness, photophobia<hr/></td>
              <td valign="top" align="left" rowspan="1" colspan="1">OU: 20/60;&#x2028;Low myopia<hr/></td>
              <td valign="top" align="left" rowspan="1" colspan="1">OU: 0/17<hr/></td>
              <td valign="top" align="left" rowspan="1" colspan="1">Subtle RPE atrophic changes at the center of both maculae<hr/></td>
              <td valign="top" align="left" rowspan="1" colspan="1">Undetectable PERG;&#x2028;Scotopic bright flash ERG is markedly delayed and subnormal;&#x2028;Severely delayed and reduced cone responses.<hr/></td>
            </tr>
            <tr>
              <td valign="top" align="left" scope="row" rowspan="1" colspan="1">3/16/F</td>
              <td valign="top" align="left" rowspan="1" colspan="1">Difficulty reading</td>
              <td valign="top" align="left" rowspan="1" colspan="1">OU: 20/40;&#x2028;Myopia</td>
              <td valign="top" align="left" rowspan="1" colspan="1">OU: 1/17</td>
              <td valign="top" align="left" rowspan="1" colspan="1">Elevated, pigmented macular lesion; normally appearing peripheral retina</td>
              <td valign="top" align="left" rowspan="1" colspan="1">PERG: severely reduced;&#x2028;Scotopic bright flash ERG is moderately subnormal;&#x2028;Severely delayed and reduced cone responses.</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <p>BCVA: Snellen best-corrected visual acuity, ERG: electroretinogram, RPE: retinal pigment epithelium. PERG: pattern electroretinogram. Color vision was tested using Ishihara plates.</p>
        </table-wrap-foot>
      </table-wrap>
      <sec>
        <title>Case 1</title>
        <p>Patient II:2 is a 24-year-old female who was referred with a 6-year history of worsening visual acuity and a preference for dimly lit environments. Her best-corrected visual acuity (BCVA) was 20/60 in each eye. She saw only 1 and 2 of the 17 Ishihara color plates with the right and left eye, respectively. Fundus examination revealed areas of pigment loss and hyperpigmentation at the level of the outer retina in both maculae (<xref ref-type="fig" rid="f2">Figure 2A</xref>). FAF showed multiple areas of reduced macular autofluorescence (AF; <xref ref-type="fig" rid="f2">Figure 2B</xref>). SD-OCT showed disruption of the photoreceptor and retinal pigment epithelium (RPE) layers at the fovea (<xref ref-type="fig" rid="f2">Figure 2C</xref>). The inner segment ellipsoid line was relatively intact, suggesting a degree of preservation of macular photoreceptors, including foveal cones. Perimetry showed relatively dense central scotomata in both eyes (<xref ref-type="fig" rid="f3">Figure 3</xref>). Full-field ERG showed a cone-rod pattern of generalized dysfunction (<xref ref-type="fig" rid="f4">Figure 4</xref>) with severely delayed and severely reduced photopic single flash (light adapted response to a 3.0 cd.s.m<sup>-2</sup> stimulus) and 30 Hz flicker ERGs (light adapted response to a 3.0 cd.s.m<sup>-2</sup> stimulus), undetectable rod-specific ERGs (dark-adapted response to a 0.01 cd.s.m<sup>-2</sup> stimulus), and markedly delayed and subnormal scotopic bright flash ERGs (dark-adapted response to a 11.0 cd.s.m<sup>-2</sup> stimulus). PERGs (<xref ref-type="fig" rid="f4">Figure 4</xref>) and multifocal ERGs (data not shown) were undetectable, in keeping with severe widespread macular involvement.</p>
        <fig id="f2" fig-type="figure" position="float">
          <label>Figure 2</label>
          <caption>
            <p>Color fundus photographs , fundus autofluorescence images, and optical coherence tomography images of cases 1, 2, and 3. <bold>A</bold>: Case 1-A mild pigment atrophy in the central macula and hyperpigmentation nasal to the fovea. <bold>B</bold>: Speckled hypoautofluorescence in the macular region. C: Irregular reflectivity at the level of the outer retinal layers. <bold>D</bold>: Case 2-Subtle pigment changes at the center of the macula. <bold>E</bold>: Normal fundus autofluorescence (FAF). <bold>F</bold>: Case 3-The retina appears normal except for a central area of dense hyperpigmentation. <bold>G</bold>: A ring of hyperautofluorescence surrounding a central bull&#x2019;s eye lesion. <bold>H</bold>: An elevated lesion is present at the center of the fovea. There is distortion of the retinal layers over and adjacent to the lesion.</p>
          </caption>
          <graphic xlink:href="mv-v19-2250-f2"/>
        </fig>
        <fig id="f3" fig-type="figure" position="float">
          <label>Figure 3</label>
          <caption>
            <p>Goldmann visual fields of both eyes of each patient using target sizes: I4e, III4e, and V4e. The left-hand column shows the fields of the left eye, while the right-hand column illustrates the fields of the right eye. Case 1 has a relatively large central scotoma; the left eye shows smaller paracentral islands of sensitivity loss. Case 2 has normal fields. Case 3 has a left central and paracentral relative scotomata to static stimuli only. The right eye field shows a small relative scotoma.</p>
          </caption>
          <graphic xlink:href="mv-v19-2250-f3"/>
        </fig>
        <fig id="f4" fig-type="figure" position="float">
          <label>Figure 4</label>
          <caption>
            <p>Electroretinograms of all cases. Bottom row: Electroretinograms (ERGs) of a control subject. No significant interocular asymmetry was present and data are only shown from one eye of each patient. DA 0.01: dark-adapted 0.01 cd.s.m<sup>&#x2212;2</sup>; DA 11.0: dark-adapted 11.0 cd.s.m<sup>&#x2212;2</sup>; LA 30 Hz: light-adapted 3.0 cd.s.m<sup>&#x2212;2</sup>, 30 Hz flicker; LA 3.0: light-adapted 3.0 cd.s.m<sup>&#x2212;2</sup>; PERG: pattern ERG.</p>
          </caption>
          <graphic xlink:href="mv-v19-2250-f4"/>
        </fig>
      </sec>
      <sec>
        <title>Case 2</title>
        <p>Patient II:3 is an 18-year-old male who was referred with a 3-year history of severely reduced visual acuity and photophobia, preferring dimly lit environments. His BCVA was 20/60 in either eye. He had no detectable color vision. Retinal examination showed subtle RPE atrophic changes at the center of both maculae (<xref ref-type="fig" rid="f2">Figure 2D</xref>). FAF imaging was normal (<xref ref-type="fig" rid="f2">Figure 2E</xref>). OCT was not available. Visual fields were normal for the II4e, III4e, and V4e targets (<xref ref-type="fig" rid="f3">Figure 3</xref>). Full-field ERGs showed a generalized cone-rod pattern of dysfunction (<xref ref-type="fig" rid="f4">Figure 4</xref>) with findings similar to those described for case 1.</p>
      </sec>
      <sec>
        <title>Case 3</title>
        <p>Patient II:6 is a 16-year-old female who had complained of difficulty reading for the past 6 months. She denied night vision problems, and was not photophobic. Her BCVA was 20/40 in either eye. She correctly identified only the screening plate of the Ishihara test when each eye was tested. Retinal examination showed bilateral dense hyperpigmentation at the center of the macula (<xref ref-type="fig" rid="f2">Figure 2F</xref>). FAF imaging showed a central region of reduced AF surrounded by alternating rings of increased and reduced AF (<xref ref-type="fig" rid="f2">Figure 2G</xref>). SD-OCT showed a localized dome-shaped foveal elevation in both eyes involving the RPE layer, which also had an uneven reflectivity (<xref ref-type="fig" rid="f2">Figure 2H</xref>). Localized hyporeflectivity was present in relation to the outer plexiform layer at the edges of these lesions. Visual field testing (<xref ref-type="fig" rid="f3">Figure 3</xref>) showed a localized central region of reduced sensitivity to static stimuli in the left eye. The right visual field showed only a small paracentral relative scotoma. Full-field ERGs showed a cone-rod pattern of generalized dysfunction with PERG evidence of severe macular involvement (<xref ref-type="fig" rid="f4">Figure 4</xref>).</p>
      </sec>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>This report describes the early clinical and electrophysiological features of cone-rod dystrophy arising from a mutation in <italic>CDHR1</italic>. All patients in the present series had visual acuity reduction starting in adolescence and rapidly developed photophobia. Color vision was severely affected in all, in keeping with previous reports, even in the youngest sibling who only had reading difficulty and relatively mild visual acuity reduction [<xref ref-type="bibr" rid="r9">9</xref>,<xref ref-type="bibr" rid="r11">11</xref>,<xref ref-type="bibr" rid="r12">12</xref>]. Consistent with previous studies, all patients were myopic [<xref ref-type="bibr" rid="r9">9</xref>,<xref ref-type="bibr" rid="r11">11</xref>,<xref ref-type="bibr" rid="r12">12</xref>]. It is not known whether this reflects an effect of the specific genetic mutation on ocular development or is a secondary response to constant blurring of the retinal image.</p>
      <p>The present mutation has been reported previously by the same group in a different pedigree [<xref ref-type="bibr" rid="r9">9</xref>]. The families in both reports are unrelated, but a founder effect cannot be excluded as both families come from the Indian subcontinent. As previously reported [<xref ref-type="bibr" rid="r9">9</xref>], the c.1463delG mutation causes truncation of the protein in the cadherin domain through a premature stop codon, 19 codons downstream of the deletion. It may lead to nonsense-mediated decay of the transcript and loss of the whole peptide chain [<xref ref-type="bibr" rid="r9">9</xref>].</p>
      <p>At presentation, despite significant symptoms and reduced acuity, fundus abnormalities can be relatively mild compared to the phenotype described previously in older subjects with mutations in <italic>CDHR1</italic>, including a patient with a similar mutation (<xref ref-type="table" rid="t2">Table 2</xref>) [<xref ref-type="bibr" rid="r9">9</xref>]. Color vision assessment was abnormal in all three individuals and may provide a useful, albeit nonspecific, early sign of this retinopathy.</p>
      <table-wrap id="t2" position="float">
        <label>Table 2</label>
        <caption>
          <title>Clinical and genetic findings in individuals with CDHR1-related retinopathy described here and elsewhere.</title>
        </caption>
        <table frame="hsides" rules="groups">
          <col width="104" span="1"/>
          <col width="73" span="1"/>
          <col width="71" span="1"/>
          <col width="137" span="1"/>
          <col width="167" span="1"/>
          <col width="121" span="1"/>
          <col width="72" span="1"/>
          <thead>
            <tr>
              <th valign="top" align="left" scope="col" rowspan="1" colspan="1">Genotype</th>
              <th valign="top" align="left" scope="col" rowspan="1" colspan="1">Predicted amino acid sequence</th>
              <th valign="top" align="left" scope="col" rowspan="1" colspan="1">Age at presentation</th>
              <th valign="top" align="left" scope="col" rowspan="1" colspan="1">Symptoms</th>
              <th valign="top" align="left" scope="col" rowspan="1" colspan="1">Retinal features</th>
              <th valign="top" align="left" scope="col" rowspan="1" colspan="1">Electroretinography</th>
              <th valign="top" align="left" scope="col" rowspan="1" colspan="1">Reference</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Homozygous c.524dupA p.Asn176GlufsX48<hr/></td>
              <td valign="top" align="left" rowspan="1" colspan="1">Loss of 637&#x2028;carboxyl amino acids<hr/></td>
              <td valign="top" align="left" rowspan="1" colspan="1">6 months - 37 years<hr/></td>
              <td valign="top" align="left" rowspan="1" colspan="1">Reduced visual acuity in the 2nd decade, nyctalopia and impaired color vision<hr/></td>
              <td valign="top" align="left" rowspan="1" colspan="1">Macular atrophic changes, extensive sheen, peripheral RPE atrophy and bone-spicule pigmentation<hr/></td>
              <td valign="top" align="left" rowspan="1" colspan="1">Markedly delayed and reduced rod and cone responses, undetectable in some cases<hr/></td>
              <td valign="top" align="left" rowspan="1" colspan="1">Ostergaard et al [<xref ref-type="bibr" rid="r10">10</xref>]<hr/></td>
            </tr>
            <tr>
              <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Homozygous c.338delG p.Gly113AlafsX2<hr/></td>
              <td valign="top" align="left" rowspan="1" colspan="1">Loss of 746 carboxyl amino acids<hr/></td>
              <td valign="top" align="left" rowspan="1" colspan="1">34, 36, 42 years<hr/></td>
              <td valign="top" align="left" rowspan="1" colspan="1">Nyctalopia in late teenage years , visual acuity is preserved until the 4th decade, deteriorated thereafter, impaired color vision<hr/></td>
              <td valign="top" align="left" rowspan="1" colspan="1">Macular atrophic changes, peripheral circular patches of RPE atrophy, bone-spicule pigmentation and vascular attenuation<hr/></td>
              <td valign="top" align="left" rowspan="1" colspan="1">Mild cone-rod dysfunction in the youngest, moderate-severe rod-cone dysfunction in the older 2 individuals<hr/></td>
              <td valign="top" align="left" rowspan="1" colspan="1">Henderson et al [<xref ref-type="bibr" rid="r9">9</xref>] (family GC16464)<hr/></td>
            </tr>
            <tr>
              <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Homozygous&#x2028;c.1381 C&gt;T p.Gln461X<hr/></td>
              <td valign="top" align="left" rowspan="1" colspan="1">Loss of 399 carboxyl amino acids<hr/></td>
              <td valign="top" align="left" rowspan="1" colspan="1">32, 36, 45 years<hr/></td>
              <td valign="top" align="left" rowspan="1" colspan="1">Glare and photosensitivity in childhood, nyctalopia in adolescence, impaired color vision by the 3rd decade, visual acuity loss by the 4th decade<hr/></td>
              <td valign="top" align="left" rowspan="1" colspan="1">Bull&#x2019;s eye pattern, peripheral RPE atrophy, bone-spicule pigmentation and vascular attenuation, relative preservation of the anatomic fovea by OCT<hr/></td>
              <td valign="top" align="left" rowspan="1" colspan="1">Undetectable<hr/></td>
              <td valign="top" align="left" rowspan="1" colspan="1">Duncan et al [<xref ref-type="bibr" rid="r12">12</xref>]<hr/></td>
            </tr>
            <tr>
              <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Homozygous c.1463delG&#x2028;(annotated c.1459delG [<xref ref-type="bibr" rid="r9">9</xref>]) p.Gly488AlafsX20<hr/></td>
              <td valign="top" align="left" rowspan="1" colspan="1">Loss of 353 carboxyl amino acids<hr/></td>
              <td valign="top" align="left" rowspan="1" colspan="1">32 years&#x2028;24, 18, 16 years<hr/></td>
              <td valign="top" align="left" rowspan="1" colspan="1">Nyctalopia in late teenage years, visual acuity is preserved until the 4th decade, deteriorated thereafter, impaired color vision. Lack of retinal signs led to suspected neurological cause for field loss at presentation [<xref ref-type="bibr" rid="r9">9</xref>].&#x2028;Reduced visual acuity in the 2nd decade, impaired color vision.<hr/></td>
              <td valign="top" align="left" rowspan="1" colspan="1">Circular macular atrophic changes, peripheral circular patches of RPE atrophy, bone-spicule pigmentation and vascular attenuation [<xref ref-type="bibr" rid="r9">9</xref>].&#x2028;Mild macular RPE changes, no peripheral retinal changes, dome-shaped subfoveal pigmented lesions, relative preservation of the anatomic fovea by OCT<hr/></td>
              <td valign="top" align="left" rowspan="1" colspan="1">Undetectable [<xref ref-type="bibr" rid="r9">9</xref>]&#x2028;Markedly delayed and reduced cone and rod responses<hr/></td>
              <td valign="top" align="left" rowspan="1" colspan="1">Henderson et al [<xref ref-type="bibr" rid="r9">9</xref>] (family GC3748)&#x2028;Present paper (family GC18832)<hr/></td>
            </tr>
            <tr>
              <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Homozygous c.1485+2T&gt;G</td>
              <td valign="top" align="left" rowspan="1" colspan="1">Elimination of intron 13 donor splice site</td>
              <td valign="top" align="left" rowspan="1" colspan="1">36, 38 years</td>
              <td valign="top" align="left" rowspan="1" colspan="1">Reduced visual acuity in the 2nd decade , nyctalopia</td>
              <td valign="top" align="left" rowspan="1" colspan="1">Macular atrophic changes, peripheral RPE atrophy, few bone-spicule pigmentation, relative preservation of the anatomic fovea by OCT</td>
              <td valign="top" align="left" rowspan="1" colspan="1">Undetectable cone response, markedly reduced rod response.</td>
              <td valign="top" align="left" rowspan="1" colspan="1">Cohen et al [<xref ref-type="bibr" rid="r11">11</xref>]</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <p>All variants are described according to the Human Genome Variation Society guidelines based on reference sequence NM_033100.3 (<italic>CDHR1</italic>)</p>
        </table-wrap-foot>
      </table-wrap>
      <p>The macular SD-OCT images of the youngest patient showed a novel finding, an irregular, dome-shaped lesion deep in the RPE, with some distortion of the structure of the overlying neurosensory retina. This is the first report of such lesions occurring in this retinopathy and further observation will be necessary to determine whether this is a characteristic early feature of the disorder, or an incidental finding in this patient.</p>
      <p>Although the retinal periphery appeared normal in all patients, the full-field cone and rod ERGs were profoundly abnormal. Electrophysiological testing is an important part of the assessment of patients with inherited retinal disorders, and can be particularly helpful in cases where the symptoms at presentation cannot be explained by the findings on ophthalmoscopy.</p>
      <p>It is clear from the symptoms, signs, and investigations, that the cone photoreceptor appears most vulnerable to an inherent lack of CDHR1. The cause of the initial vulnerability of cone photoreceptors is not suggested by the expression of these genes in both photoreceptor classes, and has yet to be determined. Moreover, the disorder, at least in the early stages, is not a form of retinitis pigmentosa, allowing it to be distinguished from the many subtypes of this class of retinal degeneration. Progressive autosomal recessive cone-rod dystrophies are rare, with only a handful of genes implicated [<xref ref-type="bibr" rid="r5">5</xref>-<xref ref-type="bibr" rid="r8">8</xref>,<xref ref-type="bibr" rid="r18">18</xref>]. As expected, the proteins involved in the formation and maintenance of the photoreceptor OS are critical for cell survival and any novel treatments would need to target this process [<xref ref-type="bibr" rid="r6">6</xref>,<xref ref-type="bibr" rid="r19">19</xref>]. The relative sparing of the outer retinal layers in the OCT images presented herein may suggest a period of time in the natural history of the disorder in which rescue may be successful.</p>
      <p>In summary, a detailed description of the clinical phenotype in three siblings with a mutation in <italic>CDHR1</italic> corroborates other reports that the disorder initially affects the cone system rather than causing retinitis pigmentosa. The data from this family give further insights into the presentation of the disorder, facilitating early diagnosis and delivery of effective genetic counseling.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgments</title>
      <p>The authors thank Dr. Magella M. Neveu, Moorfields Eye Hospital, for interpreting the electrophysiological data of one of the patients. We acknowledge Dr. Naushin Waseem, UCL Institute of Ophthalmology for performing Sanger sequencing. The work was supported by grants from the National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, Fight for Sight (including the Mercer Fund), Moorfields Eye Hospital Special Trustees, Retinitis Pigmentosa Fighting Blindness, and the Foundation Fighting Blindness (USA). MM is supported by a Foundation Fighting Blindness Career Development Award.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="r1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thiadens</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Phan</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Zekveld-Vroon</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Leroy</surname>
              <given-names>BP</given-names>
            </name>
            <name>
              <surname>van den Born</surname>
              <given-names>LI</given-names>
            </name>
            <name>
              <surname>Hoyng</surname>
              <given-names>CB</given-names>
            </name>
            <name>
              <surname>Klaver</surname>
              <given-names>CC</given-names>
            </name>
            <collab>Writing Committee for the Cone Disorders Study Group Consortium</collab>
          </person-group>
          <article-title>Roosing S, Pott JW, van Schooneveld MJ, van Moll-Ramirez N, van Genderen MM, Boon CJ, den Hollander AI, Bergen AA, De Baere E, Cremers FP, Lotery AJ. Clinical course, genetic etiology, and visual outcome in cone and cone-rod dystrophy.</article-title>
          <source>Ophthalmology</source>
          <year>2012</year>
          <volume>119</volume>
          <fpage>819</fpage>
          <lpage>26</lpage>
          <pub-id pub-id-type="pmid">22264887</pub-id>
        </element-citation>
      </ref>
      <ref id="r2">
        <label>2</label>
        <mixed-citation publication-type="book">Sunness J, Carr R. Abnormalities of cone and rod function. In: Hinton D, editor. Retina. Vol 1. 4 ed. Philadelphia, PA: Mosby; 2006. p. 509-18.</mixed-citation>
      </ref>
      <ref id="r3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Michaelides</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hardcastle</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Hunt</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Moore</surname>
              <given-names>AT</given-names>
            </name>
          </person-group>
          <article-title>Progressive cone and cone-rod dystrophies: phenotypes and underlying molecular genetic basis.</article-title>
          <source>Surv Ophthalmol</source>
          <year>2006</year>
          <volume>51</volume>
          <fpage>232</fpage>
          <lpage>58</lpage>
          <pub-id pub-id-type="pmid">16644365</pub-id>
        </element-citation>
      </ref>
      <ref id="r4">
        <label>4</label>
        <mixed-citation publication-type="book">Weleber R, Gregory-Evans K. Retinitis pigmentosa and allied disorders. In: Hinton D, editor. Retina. Vol 1. 4 ed. Philadelphia, PA: Mosby; 2006. p. 395-498.</mixed-citation>
      </ref>
      <ref id="r5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Littink</surname>
              <given-names>KW</given-names>
            </name>
            <name>
              <surname>Koenekoop</surname>
              <given-names>RK</given-names>
            </name>
            <name>
              <surname>van den Born</surname>
              <given-names>LI</given-names>
            </name>
            <name>
              <surname>Collin</surname>
              <given-names>RW</given-names>
            </name>
            <name>
              <surname>Moruz</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Veltman</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Roosing</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Zonneveld</surname>
              <given-names>MN</given-names>
            </name>
            <name>
              <surname>Omar</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Darvish</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lopez</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Kroes</surname>
              <given-names>HY</given-names>
            </name>
            <name>
              <surname>van Genderen</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Hoyng</surname>
              <given-names>CB</given-names>
            </name>
            <name>
              <surname>Rohrschneider</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>van Schooneveld</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Cremers</surname>
              <given-names>FP</given-names>
            </name>
            <name>
              <surname>den Hollander</surname>
              <given-names>AI</given-names>
            </name>
          </person-group>
          <article-title>Homozygosity mapping in patients with cone-rod dystrophy: novel mutations and clinical characterizations.</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>2010</year>
          <volume>51</volume>
          <fpage>5943</fpage>
          <lpage>51</lpage>
          <pub-id pub-id-type="pmid">20554613</pub-id>
        </element-citation>
      </ref>
      <ref id="r6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Danciger</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hendrickson</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Lyon</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Toomes</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>McHale</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Fishman</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Inglehearn</surname>
              <given-names>CF</given-names>
            </name>
            <name>
              <surname>Jacobson</surname>
              <given-names>SG</given-names>
            </name>
            <name>
              <surname>Farber</surname>
              <given-names>DB</given-names>
            </name>
          </person-group>
          <article-title>CORD9 a new locus for arCRD: mapping to 8p11, estimation of frequency, evaluation of a candidate gene.</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>2001</year>
          <volume>42</volume>
          <fpage>2458</fpage>
          <lpage>65</lpage>
          <pub-id pub-id-type="pmid">11581183</pub-id>
        </element-citation>
      </ref>
      <ref id="r7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pras</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Abu</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Rotenstreich</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Avni</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Reish</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Morad</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Reznik-Wolf</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Pras</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Cone-rod dystrophy and a frameshift mutation in the PROM1 gene.</article-title>
          <source>Mol Vis</source>
          <year>2009</year>
          <volume>15</volume>
          <fpage>1709</fpage>
          <lpage>16</lpage>
          <pub-id pub-id-type="pmid">19718270</pub-id>
        </element-citation>
      </ref>
      <ref id="r8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hameed</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Abid</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Aziz</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ismail</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mehdi</surname>
              <given-names>SQ</given-names>
            </name>
            <name>
              <surname>Khaliq</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Evidence of RPGRIP1 gene mutations associated with recessive cone-rod dystrophy.</article-title>
          <source>J Med Genet</source>
          <year>2003</year>
          <volume>40</volume>
          <fpage>616</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">12920076</pub-id>
        </element-citation>
      </ref>
      <ref id="r9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Henderson</surname>
              <given-names>RH</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Abd El Aziz</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Mackay</surname>
              <given-names>DS</given-names>
            </name>
            <name>
              <surname>Eljinini</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Zeidan</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Moore</surname>
              <given-names>AT</given-names>
            </name>
            <name>
              <surname>Bhattacharya</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Webster</surname>
              <given-names>AR</given-names>
            </name>
          </person-group>
          <article-title>Biallelic mutation of protocadherin-21 (PCDH21) causes retinal degeneration in humans.</article-title>
          <source>Mol Vis</source>
          <year>2010</year>
          <volume>16</volume>
          <fpage>46</fpage>
          <lpage>52</lpage>
          <pub-id pub-id-type="pmid">20087419</pub-id>
        </element-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ostergaard</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Batbayli</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Duno</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Vilhelmsen</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Rosenberg</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Mutations in PCDH21 cause autosomal recessive cone-rod dystrophy.</article-title>
          <source>J Med Genet</source>
          <year>2010</year>
          <volume>47</volume>
          <fpage>665</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">20805371</pub-id>
        </element-citation>
      </ref>
      <ref id="r11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cohen</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Chervinsky</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Jabaly-Habib</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Shalev</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Briscoe</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Ben-Yosef</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>A novel splice site mutation of CDHR1 in a consanguineous Israeli Christian Arab family segregating autosomal recessive cone-rod dystrophy.</article-title>
          <source>Mol Vis</source>
          <year>2012</year>
          <volume>18</volume>
          <fpage>2915</fpage>
          <lpage>21</lpage>
          <pub-id pub-id-type="pmid">23233793</pub-id>
        </element-citation>
      </ref>
      <ref id="r12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Duncan</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Roorda</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Navani</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Vishweswaraiah</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Syed</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Soudry</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ratnam</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Gudiseva</surname>
              <given-names>HV</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Gaasterland</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ayyagari</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Identification of a novel mutation in the CDHR1 gene in a family with recessive retinal degeneration.</article-title>
          <source>Arch Ophthalmol</source>
          <year>2012</year>
          <volume>130</volume>
          <fpage>1301</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">23044944</pub-id>
        </element-citation>
      </ref>
      <ref id="r13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rattner</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Smallwood</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>Williams</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Cooke</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Savchenko</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Lyubarsky</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Pugh</surname>
              <given-names>EN</given-names>
            </name>
            <name>
              <surname>Nathans</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>A photoreceptor-specific cadherin is essential for the structural integrity of the outer segment and for photoreceptor survival.</article-title>
          <source>Neuron</source>
          <year>2001</year>
          <volume>32</volume>
          <fpage>775</fpage>
          <lpage>86</lpage>
          <pub-id pub-id-type="pmid">11738025</pub-id>
        </element-citation>
      </ref>
      <ref id="r14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marmor</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Fulton</surname>
              <given-names>AB</given-names>
            </name>
            <name>
              <surname>Holder</surname>
              <given-names>GE</given-names>
            </name>
            <name>
              <surname>Miyake</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Brigell</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bach</surname>
              <given-names>M</given-names>
            </name>
            <collab>International Society for Clinical Electrophysiology of Vision</collab>
          </person-group>
          <article-title>ISCEV Standard for full-field clinical electroretinography (2008 update).</article-title>
          <source>Doc Ophthalmol</source>
          <year>2009</year>
          <volume>118</volume>
          <fpage>69</fpage>
          <lpage>77</lpage>
          <pub-id pub-id-type="pmid">19030905</pub-id>
        </element-citation>
      </ref>
      <ref id="r15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bach</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Brigell</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Hawlina</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Holder</surname>
              <given-names>GE</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>McCulloch</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Meigen</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Viswanathan</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>ISCEV standard for clinical pattern electroretinography (PERG): 2012 update.</article-title>
          <source>Doc Ophthalmol</source>
          <year>2013</year>
          <volume>126</volume>
          <fpage>1</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">23073702</pub-id>
        </element-citation>
      </ref>
      <ref id="r16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hood</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Bach</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Brigell</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Keating</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Kondo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lyons</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Marmor</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>McCulloch</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Palmowski-Wolfe</surname>
              <given-names>AM</given-names>
            </name>
            <collab>International Society For Clinical Electrophysiology of Vision</collab>
          </person-group>
          <article-title>ISCEV standard for clinical multifocal electroretinography (mfERG) (2011 edition).</article-title>
          <source>Doc Ophthalmol</source>
          <year>2012</year>
          <volume>124</volume>
          <fpage>1</fpage>
          <lpage>13</lpage>
          <pub-id pub-id-type="pmid">22038576</pub-id>
        </element-citation>
      </ref>
      <ref id="r17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sergouniotis</surname>
              <given-names>PI</given-names>
            </name>
            <name>
              <surname>Davidson</surname>
              <given-names>AE</given-names>
            </name>
            <name>
              <surname>Mackay</surname>
              <given-names>DS</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Plagnol</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Moore</surname>
              <given-names>AT</given-names>
            </name>
            <name>
              <surname>Webster</surname>
              <given-names>AR</given-names>
            </name>
          </person-group>
          <article-title>Recessive mutations in KCNJ13, encoding an inwardly rectifying potassium channel subunit, cause leber congenital amaurosis.</article-title>
          <source>Am J Hum Genet</source>
          <year>2011</year>
          <volume>89</volume>
          <fpage>183</fpage>
          <lpage>90</lpage>
          <pub-id pub-id-type="pmid">21763485</pub-id>
        </element-citation>
      </ref>
      <ref id="r18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Estrada-Cuzcano</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Neveling</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kohl</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Banin</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Rotenstreich</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Sharon</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Falik-Zaccai</surname>
              <given-names>TC</given-names>
            </name>
            <name>
              <surname>Hipp</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Roepman</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Wissinger</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Letteboer</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Mans</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Blokland</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Kwint</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Gijsen</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>van Huet</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Collin</surname>
              <given-names>RW</given-names>
            </name>
            <name>
              <surname>Scheffer</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Veltman</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Zrenner</surname>
              <given-names>E</given-names>
            </name>
            <collab>European Retinal Disease Consortium</collab>
          </person-group>
          <article-title>den Hollander AI, Klevering BJ, Cremers FP. Mutations in C8orf37, encoding a ciliary protein, are associated with autosomal-recessive retinal dystrophies with early macular involvement.</article-title>
          <source>Am J Hum Genet</source>
          <year>2012</year>
          <volume>90</volume>
          <fpage>102</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">22177090</pub-id>
        </element-citation>
      </ref>
      <ref id="r19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Maw</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Corbeil</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Koch</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Hellwig</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Wilson-Wheeler</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Bridges</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Kumaramanickavel</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>John</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Nancarrow</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>R&#xF6;per</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Weigmann</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Huttner</surname>
              <given-names>WB</given-names>
            </name>
            <name>
              <surname>Denton</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <article-title>A frameshift mutation in prominin (mouse)-like 1 causes human retinal degeneration.</article-title>
          <source>Hum Mol Genet</source>
          <year>2000</year>
          <volume>9</volume>
          <fpage>27</fpage>
          <lpage>34</lpage>
          <pub-id pub-id-type="pmid">10587575</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
